Insulin – Long Acting (Lantus)

Release Date:

Visit: https://nursing.com/140meds to request your free copy of "140 Must Know Meds" Generic Name Insulin detemir, Insulin glargine Trade Name Levemir, Lantus Indication hyperglycemia with diabetes type 1 and 2, diabetic ketoacidosis Action stimulates uptake of glucose into muscle and fat cells, inhibits production of glucose in the liver, prevents breakdown of fat and protein Route Onset Peak Duration Detemir 3-4 hr 3-14 hr 24 hr Glargine 3-4 hr none 24 hr   Therapeutic Class antidiabetics, hormones Pharmacologic Class pancreatics Nursing Considerations • assess for symptoms of hypoglycemia or hyperglycemia • monitor body weight over time • may cause decreased inorganic phosphates, potassium, and magnesium • monitor blood sugars every 6 hours, monitor A1C every 3-6 months

Insulin – Long Acting (Lantus)

Title
Insulin – Long Acting (Lantus)
Copyright
Release Date

flashback